Oncotarget

Research Papers:

Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation

Alicia Bort, Elena Spínola, Nieves Rodríguez-Henche and Inés Díaz-Laviada _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:87684-87698. https://doi.org/10.18632/oncotarget.21196

Metrics: PDF 2088 views  |   HTML 3156 views  |   ?  


Abstract

Alicia Bort1, Elena Spínola1, Nieves Rodríguez-Henche1 and Inés Díaz-Laviada1,2

1Department of Systems Biology, School of Medicine and Heath Sciences, University of Alcala, Alcalá de Henares, E-28871, Madrid, Spain

2Chemical Research Institute Andrés M. del Río (IQAR), University of Alcala, Alcalá de Henares, E-28871, Madrid, Spain

Correspondence to:

Inés Díaz-Laviada, email: [email protected]

Keywords: capsaicin, sorafenib, AMPK, Akt, hepatocellular carcinoma

Received: June 09, 2017    Accepted: August 25, 2017    Published: September 23, 2017

ABSTRACT

In this study, we investigated the antitumoral effects of combined treatment using sorafenib and capsaicin in hepatocellular carcinoma (HCC) cells. Here we showed that the combination of the two drugs had a much stronger inhibitory effect on both HepG2 and Huh-7 human HCC cells growth than either drug alone. The isobolograms demonstrated that the combinations investigated in this study produced a synergistic interaction. In the combination treatment using capsaicin and sorafenib, increased apoptosis, followed by the activation of caspase-9 and PARP, was observed. In addition, the present study demonstrated that sorafenib treatment induces activation of Akt, probably as a mechanism of resistance, whereas capsaicin inhibits Akt providing a possible pathway whereby capsaicin sensitizes to sorafenib in HCC cells. Moreover, capsaicin singly and the combination of capsaicin and sorafenib induce AMPK activation and Acetyl CoA carboxylase phosphorylation in HCC cells. Knocking down of AMPK by selective siRNA abrogates capsaicin-induced Akt inhibition, suggesting the involvement of AMPK in the antiproliferative effect. In vivo experiments further showed that that the anti-tumor effect of sorafenib was enhanced by its combination with 2.5 mg/Kg of capsaicin. Overall, these results show that combined treatment with capsaicin and sorafenib might improve sorafenib sensitivity and therefore it represents a promising and attractive strategy for the treatment of HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21196